S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Stock market today: Shares mixed in Asia ahead of updates on jobs, inflation
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
Economists predict US inflation will keep cooling and the economy can avoid a recession
Alaska Air Group announces it has agreed to buy Hawaiian Airlines in a $1.9 billion deal with debt
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Stock market today: Shares mixed in Asia ahead of updates on jobs, inflation
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
Economists predict US inflation will keep cooling and the economy can avoid a recession
Alaska Air Group announces it has agreed to buy Hawaiian Airlines in a $1.9 billion deal with debt
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Stock market today: Shares mixed in Asia ahead of updates on jobs, inflation
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
Economists predict US inflation will keep cooling and the economy can avoid a recession
Alaska Air Group announces it has agreed to buy Hawaiian Airlines in a $1.9 billion deal with debt
S&P 500   4,594.63
DOW   36,245.50
QQQ   389.94
Man kills 4 relatives in Queens knife rampage, injures 2 officers before he's fatally shot by police
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
British military reports an explosion off the coast of Yemen in the key Bab el-Mandeb Strait
Stock market today: Shares mixed in Asia ahead of updates on jobs, inflation
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
Alaska Air to buy Hawaiian Airlines in a $1.9 billion deal that may attract regulator scrutiny
Watchdog: Western arms companies failed to ramp up production capacity in 2022 due to Ukraine war
"Chilling War Games Show US Forces Crushed" – FOX NEWS (Ad)
Economists predict US inflation will keep cooling and the economy can avoid a recession
Alaska Air Group announces it has agreed to buy Hawaiian Airlines in a $1.9 billion deal with debt

Eloxx Pharmaceuticals Stock Price, News & Analysis (NASDAQ:ELOX)

$1.10
-0.04 (-3.51%)
(As of 12/1/2023 08:55 PM ET)
Compare
Today's Range
$1.10
$1.18
50-Day Range
$1.07
$4.94
52-Week Range
$0.95
$10.90
Volume
4,400 shs
Average Volume
442,473 shs
Market Capitalization
$3.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$55.00

Eloxx Pharmaceuticals MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
4,900.0% Upside
$55.00 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($7.91) to ($7.39) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.68 out of 5 stars


ELOX stock logo

About Eloxx Pharmaceuticals Stock (NASDAQ:ELOX)

Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company also develops various preclinical programs for the treatment of alport syndrome, recessive dystrophic epidermolysis bullosa, junctional epidermolysis bullosa, and familial adenomatous polyposis, as well as various earlier discovery stage programs in oncology. Eloxx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Watertown, Massachusetts.

ELOX Stock Price History

ELOX Stock News Headlines

Trading Experts Call It “The Perfect Tesla Trade”
Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.
Eloxx Pharmaceuticals Inc ELOX
Eloxx Pharmaceuticals prices $2M stock offering
Eloxx Pharmaceuticals Announces Registered Direct Offering - Quick Facts
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Eloxx Pharmaceuticals (NASDAQ: ELOX)
See More Headlines
Receive ELOX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Eloxx Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/13/2023
Today
12/03/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Biological products, except diagnostic
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ELOX
Employees
18
Year Founded
2013

Price Target and Rating

Average Stock Price Target
$55.00
High Stock Price Target
$55.00
Low Stock Price Target
$55.00
Potential Upside/Downside
+4,900.0%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-36,060,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($6.38) per share

Miscellaneous

Free Float
2,508,000
Market Cap
$3.45 million
Optionable
Not Optionable
Beta
2.66
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report














ELOX Stock Analysis - Frequently Asked Questions

Should I buy or sell Eloxx Pharmaceuticals stock right now?

1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Eloxx Pharmaceuticals in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" ELOX shares.
View ELOX analyst ratings
or view top-rated stocks.

What is Eloxx Pharmaceuticals' stock price target for 2024?

1 Wall Street research analysts have issued 1-year price objectives for Eloxx Pharmaceuticals' shares. Their ELOX share price targets range from $55.00 to $55.00. On average, they expect the company's stock price to reach $55.00 in the next year. This suggests a possible upside of 4,900.0% from the stock's current price.
View analysts price targets for ELOX
or view top-rated stocks among Wall Street analysts.

How have ELOX shares performed in 2023?

Eloxx Pharmaceuticals' stock was trading at $1.82 at the start of the year. Since then, ELOX stock has decreased by 39.6% and is now trading at $1.10.
View the best growth stocks for 2023 here
.

How were Eloxx Pharmaceuticals' earnings last quarter?

Eloxx Pharmaceuticals, Inc. (NASDAQ:ELOX) issued its quarterly earnings results on Monday, November, 13th. The company reported ($1.31) earnings per share for the quarter, topping analysts' consensus estimates of ($1.97) by $0.66.

What is Greg Williams' approval rating as Eloxx Pharmaceuticals' CEO?

1 employees have rated Eloxx Pharmaceuticals Chief Executive Officer Greg Williams on Glassdoor.com. Greg Williams has an approval rating of 49% among the company's employees. This puts Greg Williams in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. 48.0% of employees surveyed would recommend working at Eloxx Pharmaceuticals to a friend.

Who are Eloxx Pharmaceuticals' major shareholders?

Eloxx Pharmaceuticals' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Armistice Capital LLC (10.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Daniel E Geffken, Pontifax Management 4 GP (20 and Rajesh B Parekh.
View institutional ownership trends
.

How do I buy shares of Eloxx Pharmaceuticals?

Shares of ELOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:ELOX) was last updated on 12/4/2023 by MarketBeat.com Staff

My Account -